CGON:NASDAQ, CG Oncology, Inc.

CGON stock overview

CG Oncology, Inc. (CGON:NASDAQ) closed at $59.75 on October 16, 2026, down 3.41% on the day. The stock trades 26.2% below its 52-week high of $80.97 and 66.9% above its 52-week low of $35.80. Over the past year, it gained 47.8%. CG Oncology, Inc. is part of the Health Care sector.

Key figures

Price
$59.75
Day change
-3.41%
Volume
694,788
Average volume
873,365
Market cap
5B+
52-week range
$35.80 – $80.97
50-day average
$72.58
200-day average
$65.00

Performance

5D 1M 3M 6M 1Y
-2.01% -16.54% -11.87% -12.13% +47.81%

Price action over the past year

In 252 trading sessions since October 15, 2025, CGON closed higher on 123 days (49%). Its best day was January 9, 2026 (+29.26%) and its worst was October 6, 2026 (-7.38%). The stock moved 10% or more in a single session 2 times.

Recent signals

CGON news

About CG Oncology, Inc.

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life.

Similar stocks

Find more stocks like CGON with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.